Pharma 4.0™ Adoption Needs Cooperation — Here's How to Build It
The greatest barrier to digital maturity is an inadequate company culture, according to findings from an ISPE survey. In an interview with Bioprocess Online, Malcolm Jeffers with the International Academy of Automation Engineering addresses the ISPE survey findings and highlights key takeaways for organizations. Jeffers discusses the importance of culture quality when considering Pharma 4.0, outlines roles that accelerate Pharma 4.0 transformations, and more, following his presentation at the 2024 ISPE Pharma 4.0™ and Annex 1 Conference.
Learn more about ISPE conferences.
About Bioprocess Online
Bioprocess Online is part of the Life Science Connect media group. The publication provides technical information, industry knowledge, and content for the biotherapeutic community. Audiences include bioprocess engineers, scientists, bioprocessing managers, biotechnology producers, consultants, QA/QC, project managers, directors, purchasers, marketers, and those involved in the biopharmaceutical supply chain or facilities management.